Vital KSK Holdings Past Earnings Performance
Past criteria checks 4/6
Vital KSK Holdings has been growing earnings at an average annual rate of 5%, while the Healthcare industry saw earnings growing at 6% annually. Revenues have been growing at an average rate of 1.1% per year. Vital KSK Holdings's return on equity is 7.4%, and it has net margins of 1.3%.
Key information
5.0%
Earnings growth rate
7.6%
EPS growth rate
| Healthcare Industry Growth | 7.9% |
| Revenue growth rate | 1.1% |
| Return on equity | 7.4% |
| Net Margin | 1.3% |
| Next Earnings Update | 13 May 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses BreakdownBeta
How Vital KSK Holdings makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 585,491 | 7,452 | 41,229 | 0 |
| 30 Sep 23 | 584,609 | 5,741 | 41,793 | 0 |
| 30 Jun 23 | 580,793 | 5,108 | 42,505 | 0 |
| 31 Mar 23 | 579,772 | 4,831 | 42,492 | 0 |
| 31 Dec 22 | 581,110 | 4,755 | 42,799 | 0 |
| 30 Sep 22 | 581,396 | 4,796 | 42,430 | 0 |
| 30 Jun 22 | 577,854 | 4,766 | 41,469 | 0 |
| 31 Mar 22 | 577,249 | 4,770 | 41,030 | 0 |
| 31 Dec 21 | 567,530 | 3,284 | 40,383 | 0 |
| 30 Sep 21 | 555,589 | 2,144 | 40,302 | 0 |
| 30 Jun 21 | 544,871 | 2,072 | 40,200 | 0 |
| 31 Mar 21 | 537,030 | 1,171 | 40,478 | 0 |
| 31 Dec 20 | 538,560 | 344 | 41,087 | 0 |
| 30 Sep 20 | 543,656 | 2,616 | 41,309 | 0 |
| 30 Jun 20 | 554,891 | 3,332 | 41,712 | 0 |
| 31 Mar 20 | 562,505 | 4,642 | 41,689 | 0 |
| 31 Dec 19 | 566,891 | 5,384 | 41,475 | 0 |
| 30 Sep 19 | 570,255 | 4,894 | 41,559 | 0 |
| 30 Jun 19 | 560,797 | 5,110 | 41,421 | 0 |
| 31 Mar 19 | 559,712 | 5,084 | 41,670 | 0 |
| 31 Dec 18 | 557,576 | 5,557 | 41,793 | 0 |
| 30 Sep 18 | 560,359 | 5,424 | 41,782 | 0 |
| 30 Jun 18 | 564,141 | 4,546 | 41,795 | 0 |
| 31 Mar 18 | 565,589 | 4,467 | 41,394 | 0 |
| 31 Dec 17 | 569,020 | 4,225 | 41,261 | 0 |
| 30 Sep 17 | 568,083 | 4,128 | 41,315 | 0 |
| 30 Jun 17 | 572,050 | 4,102 | 41,293 | 0 |
| 31 Mar 17 | 581,079 | 4,778 | 41,403 | 0 |
| 31 Dec 16 | 604,545 | 5,626 | 42,377 | 0 |
| 30 Sep 16 | 627,483 | 6,968 | 42,344 | 0 |
| 30 Jun 16 | 630,849 | 7,252 | 42,223 | 0 |
| 31 Mar 16 | 621,040 | 6,556 | 42,023 | 0 |
| 31 Dec 15 | 594,643 | 5,186 | 40,873 | 0 |
| 30 Sep 15 | 569,285 | 3,926 | 40,561 | 0 |
| 30 Jun 15 | 558,238 | 3,439 | 40,660 | 0 |
| 31 Mar 15 | 548,012 | 4,527 | 39,742 | 0 |
| 31 Dec 14 | 551,965 | 4,871 | 38,884 | 0 |
| 30 Sep 14 | 553,914 | 4,826 | 38,309 | 0 |
| 30 Jun 14 | 556,424 | 5,239 | 37,478 | 0 |
| 31 Mar 14 | 564,655 | 4,235 | 37,922 | 0 |
| 31 Dec 13 | 557,945 | 4,024 | 37,988 | 0 |
| 30 Sep 13 | 554,022 | 3,557 | 37,969 | 0 |
| 30 Jun 13 | 550,206 | 3,589 | 37,680 | 0 |
Quality Earnings: 3151 has a large one-off gain of ¥3.4B impacting its last 12 months of financial results to 31st December, 2023.
Growing Profit Margin: 3151's current net profit margins (1.3%) are higher than last year (0.8%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 3151's earnings have grown by 5% per year over the past 5 years.
Accelerating Growth: 3151's earnings growth over the past year (56.7%) exceeds its 5-year average (5% per year).
Earnings vs Industry: 3151 earnings growth over the past year (56.7%) exceeded the Healthcare industry 8.4%.
Return on Equity
High ROE: 3151's Return on Equity (7.4%) is considered low.